InvestorsHub Logo
Followers 144
Posts 9913
Boards Moderated 0
Alias Born 06/22/2009

Re: None

Saturday, 06/25/2016 10:03:24 AM

Saturday, June 25, 2016 10:03:24 AM

Post# of 10489
Talks of buyout swirling like the wind huh?

Gale CEO has Cleared the Decks for a SALE To ROCHE
Dr. Schwartz's previous sale of Bayhill Therapuetics to Roche proves the fact Dr. Schwartz has an inside track to sell GALENA to Roche and explains many of the recent corporate activities;
-moving to SSF next door to Roche,
-expanding the Herceptin/Neuvax combination trials 2x's,
-divesting superfluous commercial assets,
-focusing exclusively on the Neuvax/ immunology franchise,
-Firing Kriegsman (i am sure he monkey wrenched the deal previously)
-and setting all the lawsuits.
THE DECKS are Now cleared for the NEUVAX Phase 3 DATA - an IDMC GO TO Completion could be the last requirement. Less

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.